BofA Securities Downgrades Core Laboratories (CLB) to Underperform
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $12.45 +0.48%
Rating Summary:
9 Buy, 13 Hold, 7 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
9 Buy, 13 Hold, 7 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BofA Securities analyst Chase Mulvehill downgraded Core Laboratories (NYSE: CLB) from Neutral to Underperform with a price target of $21.50 (from $26.50).
For an analyst ratings summary and ratings history on Core Laboratories click here. For more ratings news on Core Laboratories click here.
Shares of Core Laboratories closed at $22.31 yesterday.
You May Also Be Interested In
- Johnson Rice Upgrades Core Laboratories (CLB) to Buy
- Zedcor Inc (ZDC:CN) PT Raised to Cdn$7.75 at Desjardins
- LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
